These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32858752)

  • 21. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
    Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
    J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
    Hirst JA; Stevens RJ; Farmer AJ
    PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme.
    Yeoh E; Png D; Koh PL; Sum CF; Lim SC; Tan HH; Ubeynarayana CU; Subramaniam T
    Diabet Med; 2022 Jan; 39(1):e14733. PubMed ID: 34698420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
    Li LQ; Yao MY; Ma JX; Xue P; Li YK
    Endocr J; 2019 Oct; 66(10):871-880. PubMed ID: 31243192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes.
    Mo Y; Ma X; Lu J; Shen Y; Wang Y; Zhang L; Lu W; Zhu W; Bao Y; Zhou J
    J Diabetes Investig; 2021 Jun; 12(6):1025-1034. PubMed ID: 33119969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleeping disturbances and predictor risk factors among type 2 diabetic mellitus patients.
    Bener A; Al-Hamaq AOAA; Agan AF; Öztürk M; Ömer A
    Ann Afr Med; 2020; 19(4):230-236. PubMed ID: 33243945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
    Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
    Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of flash glucose monitoring on glycemic control in participants with diabetes mellitus: A meta-analysis of randomized controlled trials.
    Gao Y; Zhou M; Xu X; Chen WY
    J Diabetes Complications; 2022 Nov; 36(11):108314. PubMed ID: 36208566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes.
    Rosenstock J; Jelaska A; Frappin G; Salsali A; Kim G; Woerle HJ; Broedl UC;
    Diabetes Care; 2014 Jul; 37(7):1815-23. PubMed ID: 24929430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus.
    Engler B; Koehler C; Hoffmann C; Landgraf W; Bilz S; Schoner C; Bornstein SR; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):59-61. PubMed ID: 21246466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
    Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1.
    Kramer G; Michalak L; Müller UA; Kloos C; Werner C; Kuniss N
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(4):303-308. PubMed ID: 31185506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of vildagliptin versus saxagliptin on daily acute glucose fluctuations in Chinese patients with T2DM inadequately controlled with a combination of metformin and sulfonylurea.
    Xiaoyan C; Jing W; Xiaochun H; Yuyu T; Shunyou D; Yingyu F
    Curr Med Res Opin; 2016 Jun; 32(6):1131-6. PubMed ID: 26950829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of oral antidiabetic drugs on hyperglycemic response to foods in persons with type 2 diabetes mellitus as assessed by continuous glucose monitoring system: a pilot study.
    Karolina P; Chlup R; Jana Z; Kohnert KD; Kudlova P; Bartek J; Nakladalova M; Doubravova B; Seckar P
    J Diabetes Sci Technol; 2010 Jul; 4(4):983-92. PubMed ID: 20663465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study.
    Tumminia A; Milluzzo A; Festa C; Fresa R; Pintaudi B; Scavini M; Vitacolonna E; Napoli A; Sciacca L
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1851-1859. PubMed ID: 33975741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
    Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
    Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study.
    Elliott T; Beca S; Beharry R; Tsoukas MA; Zarruk A; Abitbol A
    Diab Vasc Dis Res; 2021; 18(4):14791641211021374. PubMed ID: 34275385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.